2589-9864

Epilepsy & Behavior Reports

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 545 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact545 DOIs
2

Attach ORCID iDs across 289 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact289 DOIs
3

Deposit reference lists for 11 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact11 DOIs

DOIs for this ISSN

Showing the top 5 of 545 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The nose has it: Opportunities and challenges for intranasal… (10.1016/j.ebr.2022.100581)
Abstract ORCID
93.46 73
2 Changing the culture of care for children and adolescents wi… (10.1016/j.ebr.2021.100486)
Abstract ORCID
84.06 47
3 Using evidence-based psychotherapy to tailor treatment for p… (10.1016/j.ebr.2021.100478)
Abstract ORCID
82.66 44
4 A historical review of functional neurological disorder and… (10.1016/j.ebr.2021.100489)
Abstract ORCID
78.41 36
5 Making the switch: From case studies to N-of-1 trials (10.1016/j.ebr.2019.100336)
Abstract ORCID
76.57 33
6 The IDH1 inhibitor ivosidenib improved seizures in a patient… (10.1016/j.ebr.2022.100526)
Abstract ORCID
75.26 31
7 Infantile spasms: Etiology, lead time and treatment response… (10.1016/j.ebr.2020.100397)
Abstract ORCID
74.57 30
8 Treatment of vagus nerve stimulator-induced sleep-disordered… (10.1016/j.ebr.2019.100325)
Abstract ORCID
71.57 26
9 Functional neurological disorder: Engaging patients in treat… (10.1016/j.ebr.2021.100499)
Abstract ORCID
70.75 25
10 Overlapping demyelinating syndrome and anti-N-methyl-d-aspar… (10.1016/j.ebr.2019.100338)
Abstract ORCID
69.01 23
11 Remote delivery of cognitive behavioral therapy to patients… (10.1016/j.ebr.2021.100469)
Abstract ORCID
68.09 22
12 Effectiveness and safety of adjunctive cenobamate for focal… (10.1016/j.ebr.2022.100533)
Abstract ORCID
68.09 22
13 Knowledge of Epilepsy and seizure first aid among teachers i… (10.1016/j.ebr.2021.100475)
Abstract ORCID
67.12 21
14 Subjective versus objective measures of distress, arousal an… (10.1016/j.ebr.2021.100502)
Abstract ORCID
67.12 21
15 The Epileptic Heart Syndrome: Epidemiology, pathophysiology… (10.1016/j.ebr.2024.100696)
Abstract ORCID
65.05 19
16 Seizure control after late introduction of anakinra in a pat… (10.1016/j.ebr.2021.100462)
Abstract ORCID
63.94 18
17 Extending the reach of science – Talk in plain language (10.1016/j.ebr.2021.100493)
Abstract ORCID
63.94 18
18 Neurostimulation for the treatment of functional neurologica… (10.1016/j.ebr.2021.100501)
Abstract ORCID
62.76 17
19 Functional movement disorder and functional seizures: What h… (10.1016/j.ebr.2021.100510)
Abstract ORCID
62.76 17
20 Incidence and prevalence of major epilepsy-associated brain… (10.1016/j.ebr.2022.100527)
Abstract ORCID
62.76 17
21 Early epilepsy surgery for non drug-resistant patients (10.1016/j.ebr.2022.100542)
Abstract ORCID
61.52 16
22 Identifying and evaluating novel treatment targets for the d… (10.1016/j.ebr.2021.100479)
Abstract ORCID
60.21 15
23 Impact of epilepsy training on school teachers and counselor… (10.1016/j.ebr.2020.100365)
Abstract ORCID
58.80 14
24 Functional seizures are not less important than epilepsy (10.1016/j.ebr.2021.100495)
Abstract ORCID
58.80 14
25 One-year follow-up of treatment outcomes and patient opinion… (10.1016/j.ebr.2021.100503)
Abstract ORCID
58.80 14
26 Long-term seizure freedom following intracranial sEEG monito… (10.1016/j.ebr.2019.100345)
Abstract ORCID
57.31 13
27 Rituximab in Rasmussen’s encephalitis: A single center exper… (10.1016/j.ebr.2022.100540)
Abstract ORCID
57.31 13
28 Variable treatment response in a patient with pyridoxal N ph… (10.1016/j.ebr.2020.100357)
Abstract ORCID
55.70 12
29 Posterior-onset Rasmussen's encephalitis with ipsilateral ce… (10.1016/j.ebr.2020.100360)
Abstract ORCID
55.70 12
30 Acute modulation of the limbic network with low and high-fre… (10.1016/j.ebr.2020.100363)
Abstract ORCID
55.70 12
31 Severe drug-induced liver injury caused by levetiracetam – A… (10.1016/j.ebr.2021.100464)
Abstract ORCID
55.70 12
32 Ketogenic diet in Zambia: Managing drug-resistant epilepsy i… (10.1016/j.ebr.2020.100380)
Abstract ORCID
53.96 11
33 Knowledge and attitude of the community towards epilepsy in… (10.1016/j.ebr.2020.100422)
Abstract ORCID
53.96 11
34 Network radiofrequency ablation for drug resistant epilepsy (10.1016/j.ebr.2021.100471)
Abstract ORCID
53.96 11
35 Ambulatory EEG: Crossing the divide during a pandemic (10.1016/j.ebr.2021.100500)
Abstract ORCID
53.96 11
36 Fighting autoinflammation in FIRES: The role of interleukins… (10.1016/j.ebr.2022.100531)
Abstract ORCID
53.96 11
37 Anterior thalamic deep brain stimulation in epilepsy patient… (10.1016/j.ebr.2022.100563)
Abstract ORCID
53.96 11
38 Acute liver failure in a military recruit treated with valpr… (10.1016/j.ebr.2019.100342)
Abstract ORCID
52.07 10
39 Resolution of EEG findings and clinical improvement in a pat… (10.1016/j.ebr.2020.100379)
Abstract ORCID
52.07 10
40 Fenfluramine in the successful treatment of super-refractory… (10.1016/j.ebr.2021.100461)
Abstract ORCID
52.07 10
41 Overnight switch from levetiracetam to brivaracetam. Safety… (10.1016/j.ebr.2021.100504)
Abstract ORCID
52.07 10
42 Neurology residents’ education in functional seizures (10.1016/j.ebr.2021.100517)
Abstract ORCID
52.07 10
43 A review of the clinical spectrum of BRAT1 disorders and cas… (10.1016/j.ebr.2022.100549)
Abstract ORCID
52.07 10
44 Effectiveness and tolerability of lacosamide in children wit… (10.1016/j.ebr.2022.100574)
Abstract ORCID
52.07 10
45 GNAO1-related neurodevelopmental disorder: Literature review… (10.1016/j.ebr.2022.100582)
Abstract ORCID
52.07 10
46 The psychosocial impact of caring for children with Dravet S… (10.1016/j.ebr.2023.100619)
Abstract ORCID
52.07 10
47 A preliminary study of the effects of cannabidiol (CBD) on b… (10.1016/j.ebr.2019.100341)
Abstract ORCID
50.00 9
48 Cortical and thalamic electrode implant followed by temporar… (10.1016/j.ebr.2020.100390)
Abstract ORCID
50.00 9
49 The role of evidence-based guidelines in the diagnosis and t… (10.1016/j.ebr.2021.100494)
Abstract ORCID
50.00 9
50 Intravenous ganaxolone in pediatric super-refractory status… (10.1016/j.ebr.2022.100567)
Abstract ORCID
50.00 9